Repligen Corporation Revenue and Competitors

Claim your profile

Boston, MA USA

Location

$918.2M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Repligen Corporation's estimated annual revenue is currently $592.7M per year.(i)
  • Repligen Corporation received $138.0M in venture funding in June 2017.
  • Repligen Corporation's estimated revenue per employee is $509,158
  • Repligen Corporation's total funding is $918.2M.
  • Repligen Corporation's current valuation is $10.7B. (January 2022)

Employee Data

  • Repligen Corporation has 1164 Employees.(i)
  • Repligen Corporation grew their employee count by 26% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$0.2M1-99%N/AN/A
#2
$3.1M20233%N/AN/A
#3
$21.5M13918%$351MN/A
#4
$18M1165%$312.8MN/A
#5
$235M418-23%$340.9MN/A
#6
$2.2M3417%N/AN/A
#7
$6M40-9%$176.5MN/A
#8
$109.4M70614%N/AN/A
#9
$6.2M40233%N/AN/A
#10
$1.9M12-20%N/AN/A

Repligen is a bioprocessing-focused life sciences company bringing over 35 years of expertise and innovation to our customers. We are inspiring advances in bioprocessing through the development and commercialization of high-value products and flexible solutions that address critical steps in the production of biologic drugs, principally monoclonal antibodies. Our manufacturing facilities are located at our Waltham, Massachusetts headquarters in the USA, and in Lund, Sweden, Weingarten, Germany , Rancho Dominguez, CA and Shrewsbury, MA. We market our products globally through a direct commercial organization in the U.S., Europe and Asia, as well as through strategic partners in select markets.

keywords:Biotechnology,Healthcare,Pharmaceuticals

$918.2M

Total Funding

1164

Number of Employees

$592.7M

Revenue (est)

26%

Employee Growth %

$10.7B

Valuation

N/A

Accelerator

Repligen Corporation News

2022-04-20 - Protein A Resin Market Size And Forecast | Purolite ...

... PerkinElmer, GE Healthcare, Merck Millipore, Repligen Corporation, Thermo Fisher Scientific, Tosoh Bioscience and among others.

2022-04-19 - The total return for Repligen (NASDAQ:RGEN) investors has risen faster than earnings growth over the last five years

While Repligen Corporation (NASDAQ:RGEN) shareholders are probably generally happy, the stock hasn't had particularly good run recently,...

2022-04-13 - Repligen Corporation (RGEN) is down -12.00% in a Week, Should You Accumulate?

Repligen Corporation also received an overall rating of 53, putting it above 53% of all stocks. Medical Instruments & Supplies is ranked 116 out...

2019-09-09 - Here's Why Repligen Corporation (RGEN) Dropped -1.3%

In its most recent trading session, Repligen Corporation (RGEN) dropped by -1.3% – here is what that looked like (as of 2019-09-09): ...

2019-09-08 - What Should Investors Know About Repligen Corporation's ...

Based on Repligen Corporation's (NASDAQ:RGEN) earnings update in June 2019, analyst forecasts seem fairly subdued, as a 8.4% rise in ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$442.3M11700%N/A
#2
$237.2M118517%$423.2M
#3
$257.6M1423-3%$26.9M
#4
$494.2M168113%N/A
#5
$355.7M1731175%N/A

Repligen Corporation Funding

DateAmountRoundLead InvestorsReference
2003-05-05$12.5MPrivate PlacementArticle
2014-06-20$4.0MUndisclosedArticle
2017-06-29$138.0MUndisclosedJ.P. Morgan Securities LLCArticle